+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cell & Gene Therapy Cold Chain Logistics Market Report 2024-2034

  • PDF Icon

    Report

  • 359 Pages
  • June 2024
  • Region: Global
  • Visiongain
  • ID: 5808862
Overall world revenue for Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034 in terms of value the market will surpass US$1,800 million in 2024, the work calculates. The publisher predicts strong revenue growth through to 2034. The work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Cell and Gene Therapy Cold Chain Logistics Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

High Cancer Prevalence is Propelling the Adoption of Cell and Gene Therapies

The global incidence of cancer has been rising steadily over the past decade, significantly influencing the adoption of advanced treatments like cell and gene therapies. This increase includes various cancers such as lymphoma, leukemia, myeloma, and melanoma, which affect critical bodily systems including the lymphatic system, lymph nodes, bone marrow, and blood cells. PAHO/WHO reported that in 2023, there were around 20 million new cancer cases. Projections indicate a notable increase in the global cancer burden, with over 28 million new cases expected by 2040. In the U.S., Non-Hodgkin lymphoma alone accounts for more than 4% of all cancer cases, making it one of the most prevalent types. These statistics underscore the urgent need for innovative treatments. Cell and gene therapies, which have shown remarkable success and received regulatory approval, are increasingly seen as vital to addressing the unmet medical needs of cancer patients worldwide.

Inadequate Infrastructure for Cold Chain Logistics in Developing Nations Likely to Challenge Industry Growth

Access to cell and gene therapies in developing and remote regions is significantly restricted by inadequate cold chain logistics infrastructure. The reliability of refrigeration is often compromised by inconsistent power supplies, leading to a heightened risk of product spoilage. Transportation infrastructure in these regions also poses a major challenge, complicating the timely delivery of therapies and resulting in delays. Overcoming these logistical barriers requires strategic partnerships with local logistics providers, such as Riders for Health in Africa, to ensure effective distribution networks.

Furthermore, the shortage of trained personnel in cold chain management exacerbates these issues, emphasizing the need for specialized training programs. Collaborations between global organizations like the WHO and local authorities are essential to enhancing cold chain logistics capabilities. Such partnerships can significantly improve the infrastructure needed to support the widespread availability of cell and gene therapies, ultimately expanding access to these critical treatments in underserved regions.

Key Questions Answered

  • How is the cell and gene therapy cold chain logistics market evolving?
  • What is driving and restraining the cell and gene therapy cold chain logistics market?
  • How will each cell and gene therapy cold chain logistics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each cell and gene therapy cold chain logistics submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading cell and gene therapy cold chain logistics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the cell and gene therapy cold chain logistics projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of cell and gene therapy cold chain logistics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the cell and gene therapy cold chain logistics market?
  • Where is the cell and gene therapy cold chain logistics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the cell and gene therapy cold chain logistics market today, and over the next 10 years:

  • This 359-page report provides 146 tables and 198 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), and recent developments.

Segments Covered in the Report

Component

  • Cryogenic Shippers
  • Cryogenic Storage Freezers
  • Ultra-Low Freezers
  • Cold Chain Management Systems
  • Shipment and Storage Medium
  • Cryogenic Packout Kits
  • Others

Services

  • Transportation
  • Storage
  • Packaging

Mode of Transport

  • Air Transport
  • Ground Transport
  • Water Transport

Holding Temperature Range

  • Cryogenic
  • Refrigerated
  • Ambient
  • Others

End-users

  • Biopharmaceutical and Biotechnology Companies
Academic & Research Institutes

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 23 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Switzerland
  • Belgium
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Malaysia
  • Thailand
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles for some of the leading companies in the Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

  • A.P. Moller - Maersk
  • Arvato SE
  • Atelerix Ltd.
  • BioLife Solutions Inc.
  • BioStor Sytems Inc.
  • Cardinal Health
  • Catalent Inc.
  • Cencora, Inc.
  • CryoPort Inc.
  • DHL
  • FedEx
  • Marken (a UPS Company)
  • MasterControl Solutions, Inc.
  • Modality Solutions
  • NMDP BioTherapies
  • Nordic Cold Chain Solutions
  • sedApta s.r.l.
  • Polar Express Transportation
  • Thermo Fisher Scientific Inc.
  • TrakCel
  • Yourway

How will the Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034 report help you?

In summary, the 350+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034, with forecasts for component, services, mode of transport, holding temperature range, and end-user, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 23 key national markets - See forecasts for the Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Switzerland, Belgium, Japan, China, India, Australia, South Korea, Singapore, Malaysia, Thailand, Brazil, Mexico, Argentina, GCC, and South Africa among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 21 of the major companies involved in the Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Cell and Gene Therapy Cold Chain Logistics Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Cell and Gene Therapy Cold Chain Logistics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Advancements in Storage and Transportation of Biologics
3.3.1.2 Increasing Adoption of Gene and Cell Therapies
3.3.1.3 High Prevalence of Cancer and Genetic Disorders
3.3.1.4 Increasing Strategic Initiatives Among Market Players
3.3.2 Market Restraining Factors
3.3.2.1 High Cost of Cell and Gene Therapy Storage and Transportation
3.3.2.2 Absence of Adequate Infrastructure for Cold Chain Logistics in Developing Nations
3.3.3 Market Opportunities
3.3.3.1 Strong Clinical Pipeline and Increasing Approval for Cell and Gene Therapy Products
3.3.3.2 Lucrative Opportunities in Developing Countries
3.3.3.3 Stringent Government Regulations for Cell & Gene Therapy
3.3.3.4 Favourable Initiatives and Programs for Easier Access to Cell and Gene Therapy
3.4 Regulatory Framework
3.5 Emerging Markets and Megatrends
3.6 Porter’s Five Forces Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Competitive Rivalry
3.6.4 Threat from Substitutes
3.6.5 Threat of New Entrants
3.7 PEST Analysis
4 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Components
4.1 Key Findings
4.2 Components Segment: Market Attractiveness Index
4.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
4.4 Cryogenic Shippers
4.4.1 Market Size by Region, 2024-2034 (US$ Million)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Cryogenic Storage Freezers
4.5.1 Market Size by Region, 2024-2034 (US$ Million)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Ultra-Low Freezers
4.6.1 Market Size by Region, 2024-2034 (US$ Million)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Cold Chain Management Systems
4.7.1 Market Size by Region, 2024-2034 (US$ Million)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Shipment and Storage Medium
4.8.1 Market Size by Region, 2024-2034 (US$ Million)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Cryogenic Packout Kits
4.9.1 Market Size by Region, 2024-2034 (US$ Million)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Others
4.10.1 Market Size by Region, 2024-2034 (US$ Million)
4.10.2 Market Share by Region, 2024 & 2034 (%)
5 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Services
5.1 Key Findings
5.2 Services Segment: Market Attractiveness Index
5.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
5.4 Transportation
5.4.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Storage
5.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Packaging
5.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.6.2 Market Share by Region, 2024 & 2034 (%)
6 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Mode of Transport
6.1 Key Findings
6.2 Mode of Transport Segment: Market Attractiveness Index
6.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
6.4 Air Transport
6.4.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Ground Transport
6.5.1 Market Size by Region, 2024-2034 (US$ Million)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Water Transport
6.6.1 Market Size by Region, 2024-2034 (US$ Million)
6.6.2 Market Share by Region, 2024 & 2034 (%)
7 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Holding Temperature
7.1 Key Findings
7.2 Holding Temperature Segment: Market Attractiveness Index
7.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
7.4 Cryogenic
7.4.1 Market Size by Region, 2024-2034 (US$ Million)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 Refrigerated
7.5.1 Market Size by Region, 2024-2034 (US$ Million)
7.5.2 Market Share by Region, 2024 & 2034 (%)
7.6 Ambient
7.6.1 Market Size by Region, 2024-2034 (US$ Million)
7.6.2 Market Share by Region, 2024 & 2034 (%)
7.7 Others
7.7.1 Market Size by Region, 2024-2034 (US$ Million)
7.7.2 Market Share by Region, 2024 & 2034 (%)
8 Cell and Gene Therapy Cold Chain Logistics Market Analysis by End-users
8.1 Key Findings
8.2 End-users Segment: Market Attractiveness Index
8.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-User
8.4 Biopharmaceutical and Biotechnology Companies
8.4.1 Market Size by Region, 2024-2034 (US$ Million)
8.4.2 Market Share by Region, 2024 & 2034 (%)
8.5 Academic & Research Institutes
8.5.1 Market Size by Region, 2024-2034 (US$ Million)
8.5.2 Market Share by Region, 2024 & 2034 (%)
8.6 Others
8.6.1 Market Size by Region, 2024-2034 (US$ Million)
8.6.2 Market Share by Region, 2024 & 2034 (%)
9 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast
10 North America Cell and Gene Therapy Cold Chain Logistics Market Analysis
10.1 Key Findings
10.2 North America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
10.3 North America Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
10.5 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
10.6 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
10.7 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
10.8 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
10.9 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
10.10 U.S. Cell and Gene Therapy Cold Chain Logistics Market Analysis
10.11 Canada Cell and Gene Therapy Cold Chain Logistics Market Analysis
11 Europe Cell and Gene Therapy Cold Chain Logistics Market Analysis
11.1 Key Findings
11.2 Europe Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
11.3 Europe Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
11.5 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
11.6 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
11.7 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
11.8 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
11.9 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
11.10 Germany Cell and Gene Therapy Cold Chain Logistics Market Analysis
11.11 UK Cell and Gene Therapy Cold Chain Logistics Market Analysis
11.12 France Cell and Gene Therapy Cold Chain Logistics Market Analysis
11.13 Italy Cell and Gene Therapy Cold Chain Logistics Market Analysis
11.14 Spain Cell and Gene Therapy Cold Chain Logistics Market Analysis
11.15 Russia Cell and Gene Therapy Cold Chain Logistics Market Analysis
11.16 Switzerland Cell and Gene Therapy Cold Chain Logistics Market Analysis
11.17 Belgium Cell and Gene Therapy Cold Chain Logistics Market Analysis
11.18 Rest of Europe Cell and Gene Therapy Cold Chain Logistics Market Analysis
12 Asia Cell and Gene Therapy Cold Chain Logistics Market Analysis
12.1 Key Findings
12.2 Asia Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
12.3 Asia Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
12.5 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
12.6 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
12.7 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
12.8 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
12.9 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
12.10 Japan Cell and Gene Therapy Cold Chain Logistics Market Analysis
12.11 China Cell and Gene Therapy Cold Chain Logistics Market Analysis
12.12 India Cell and Gene Therapy Cold Chain Logistics Market Analysis
12.13 Australia Cell and Gene Therapy Cold Chain Logistics Market Analysis
12.14 South Korea Cell and Gene Therapy Cold Chain Logistics Market Analysis
12.15 Singapore Cell and Gene Therapy Cold Chain Logistics Market Analysis
12.16 Malaysia Cell and Gene Therapy Cold Chain Logistics Market Analysis
12.17 Thailand Cell and Gene Therapy Cold Chain Logistics Market Analysis
12.18 Rest of Asia Cell and Gene Therapy Cold Chain Logistics Market Analysis
13 Latin America Cell and Gene Therapy Cold Chain Logistics Market Analysis
13.1 Key Findings
13.2 Latin America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
13.3 Latin America Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
13.4 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
13.5 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
13.6 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
13.7 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
13.8 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
13.9 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
13.10 Brazil Cell and Gene Therapy Cold Chain Logistics Market Analysis
13.11 Mexico Cell and Gene Therapy Cold Chain Logistics Market Analysis
13.12 Argentina Cell and Gene Therapy Cold Chain Logistics Market Analysis
13.13 Rest of Latin America Cell and Gene Therapy Cold Chain Logistics Market Analysis
14 MEA Cell and Gene Therapy Cold Chain Logistics Market Analysis
14.1 Key Findings
14.2 MEA Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
14.3 MEA Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
14.4 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
14.5 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
14.6 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
14.7 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
14.8 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
14.9 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
14.10 GCC Cell and Gene Therapy Cold Chain Logistics Market Analysis
14.11 South Africa Cell and Gene Therapy Cold Chain Logistics Market Analysis
14.12 Rest of MEA Cell and Gene Therapy Cold Chain Logistics Market Analysis
15 Company Profiles
15.1 Company Share Analysis, 2023
15.2 Strategic Outlook
15.3 Cencora, Inc.
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2019-2023
15.3.3.2 Regional Market Shares, 2023
15.3.4 Service Benchmarking
15.3.5 Strategic Outlook
15.3.6 SWOT Analysis
15.4 Arvato SE
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Service Benchmarking
15.4.4 Strategic Outlook
15.5 Polar Express Transportation
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Service Benchmarking
15.6 NMDP BioTherapies
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Service Benchmarking
15.6.4 Strategic Outlook
15.7 BioLife Solutions, Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2019-2023
15.7.3.2 R&D, 2019-2023
15.7.3.3 Segment Market Shares, 2023
15.7.4 Service Benchmarking
15.7.5 Strategic Outlook
15.7.6 SWOT Analysis
15.8 Cardinal Health
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2019-2023
15.8.3.2 Regional Market Shares, 2023
15.8.3.3 Segment Market Shares, 2023
15.8.4 Service Benchmarking
15.8.5 Strategic Outlook
15.8.6 SWOT Analysis
15.9 Catalent, Inc.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2019-2023
15.9.3.2 Regional Market Shares, 2023
15.9.3.3 Segment Market Shares, 2023
15.9.4 Service Benchmarking
15.9.5 Strategic Outlook
15.9.6 SWOT Analysis
15.10 Cryoport Inc.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2019-2023
15.10.3.2 Regional Market Shares, 2023
15.10.3.3 Segment Market Shares, 2023
15.10.4 Service Benchmarking
15.10.5 Strategic Outlook
15.10.6 SWOT Analysis
15.11 BioStor Sytems, Inc.
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Service Benchmarking
15.12 Marken (a UPS Company)
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Service Benchmarking
15.12.4 Strategic Outlook
15.12.5 SWOT Analysis
15.13 DHL
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Service Benchmarking
15.13.4 Financial Analysis
15.13.4.1 Net Revenue, 2019-2023
15.13.4.2 Regional Market Shares, 2023
15.13.4.3 Segment Market Shares, 2023
15.13.5 Strategic Outlook
15.13.6 SWOT Analysis
15.14 FedEx
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Service Benchmarking
15.14.4 Financial Analysis
15.14.4.1 Net Revenue, 2019-2023
15.14.4.2 Regional Market Shares, 2023
15.14.5 Strategic Outlook
15.14.6 SWOT Analysis
15.15 Thermo Fisher Scientific Inc.
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Service Benchmarking
15.15.4 Strategic Outlook
15.16 Yourway
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Service Benchmarking
15.16.4 Strategic Outlook
15.17 A.P. Moller - Maersk
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue, 2019-2023
15.17.3.2 Regional Market Shares, 2023
15.17.3.3 Segment Market Shares, 2023
15.17.4 Service Benchmarking
15.17.5 Strategic Outlook
15.17.6 SWOT Analysis
15.18 Atelerix Ltd.
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Service Benchmarking
15.18.4 Strategic Outlook
15.19 Nordic Cold Chain Solutions
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Service Benchmarking
15.19.4 Strategic Outlook
15.20 MasterControl Solutions, Inc.
15.20.1 Company Snapshot
15.20.2 Company Overview
15.20.3 Service Benchmarking
15.21 TrakCel
15.21.1 Company Snapshot
15.21.2 Company Overview
15.21.3 Service Benchmarking
15.21.4 Strategic Outlook
15.22 Modality Solutions
15.22.1 Company Snapshot
15.22.2 Company Overview
15.22.3 Service Benchmarking
15.23 SedApta s.r.l.
15.23.1 Company Snapshot
15.23.2 Company Overview
15.23.3 Service Benchmarking
15.23.4 Strategic Outlook
16 Conclusion and Recommendations
16.1 Concluding Remarks
16.2 Recommendations for Market Players
List of Tables
Table 1 Cell and Gene Therapy Cold Chain Logistics Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
Table 2 Major FDA Approved Cell and Gene Therapies
Table 3 Clinical Pipeline: Major Cell and Gene Therapies
Table 4 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 5 Cryogenic Shippers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 6 Cryogenic Storage Freezers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 7 Ultra-Low Freezers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 8 Cold Chain Management Systems Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 9 Shipment and Storage Medium Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 10 Cryogenic Packout Kits Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 11 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 12 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 13 Transportation Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 14 Storage Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 15 Packaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 16 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 17 Air Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 18 Ground Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 19 Water Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 20 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 21 Cryogenic Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 22 Refrigerated Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 23 Ambient Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 25 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 26 Biopharmaceutical and Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 27 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 28 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 29 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 30 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 31 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 32 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 33 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 34 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 35 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 36 U.S. Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 37 Canada Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 38 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 39 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 40 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 41 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 42 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 43 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 44 Germany Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 45 UK Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 46 France Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 47 Italy Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 48 Spain Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 49 Russia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 50 Switzerland Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 51 Belgium Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 52 Rest of Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 53 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 54 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 55 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 56 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 57 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 58 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 59 Japan Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 60 China Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 61 India Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 62 Australia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 63 South Korea Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 64 Singapore Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 65 Malaysia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 66 Thailand Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 67 Rest of Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 68 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 69 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 70 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 71 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 72 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 73 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 74 Brazil Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 75 Mexico Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 76 Argentina Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 77 Rest of Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 78 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 79 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 80 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 81 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 82 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 83 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 84 GCC Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 85 South Africa Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 86 Rest of MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 87 Strategic Outlook
Table 88 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Cencora, Inc.: Service Benchmarking
Table 90 Cencora, Inc: Strategic Outlook
Table 91 Arvato SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Arvato SE: Service Benchmarking
Table 93 Arvato SE Strategic Outlook
Table 94 Polar Express Transportation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Polar Express Transportation: Service Benchmarking
Table 96 NMDP BioTherapies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 NMDP BioTherapies: Service Benchmarking
Table 98 NMDP BioTherapies Strategic Outlook
Table 99 BioLife Solution Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 BioLife Solution Inc.: Service Benchmarking
Table 101 BioLife Solution Inc. Strategic Outlook
Table 102 Cardinal Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Cardinal Health: Service Benchmarking
Table 104 Cardinal Health: Strategic Outlook
Table 105 Catalent Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Catalent Inc.: Service Benchmarking
Table 107 Catalent Inc. Strategic Outlook
Table 108 Cryoport Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Cryoport Inc.: Service Benchmarking
Table 110 Cryoport Strategic Outlook
Table 111 BioStor Sytems, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 BioStor Sytems, Inc.: Service Benchmarking
Table 113 Marken (a UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Marken (a UPS Company): Service Benchmarking
Table 115 Marken (a UPS Company) Strategic Outlook
Table 116 DHL: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 DHL: Service Benchmarking
Table 118 DHL: Strategic Outlook
Table 119 FedEx : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 FedEx : Service Benchmarking
Table 121 FedEx : Strategic Outlook
Table 122 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Thermo Fisher Scientific Inc.: Service Benchmarking
Table 124 Thermo Fisher Scientific Inc. Strategic Outlook
Table 125 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Yourway: Service Benchmarking
Table 127 Yourway: Strategic Outlook
Table 128 A.P. Moller - Maersk: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 A.P. Moller - Maersk: Service Benchmarking
Table 130 A.P. Moller - Maersk: Strategic Outlook
Table 131 Atelerix Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Atelerix Ltd: Service Benchmarking
Table 133 Atelerix Ltd: Strategic Outlook
Table 134 Nordic Cold Chain Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 Nordic Cold Chain Solutions: Service Benchmarking
Table 136 Nordic Cold Chain Solutions: Strategic Outlook
Table 137 MasterControl Solutions, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 MasterControl Solutions, Inc.: Service Benchmarking
Table 139 TrakCel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 TrakCel: Service Benchmarking
Table 141 TrakCel: Strategic Outlook
Table 142 Modality Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 Modality Solutions: Service Benchmarking
Table 144 sedApta s.r.l.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 sedApta s.r.l.: Service Benchmarking
Table 146 sedApta s.r.l.: Strategic Outlook
List of Figures
Figure 1 Cell and Gene Therapy Cold Chain Logistics Market Segmentation
Figure 2 Cell and Gene Therapy Cold Chain Logistics Market by Component: Market Attractiveness Index
Figure 3 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Services
Figure 4 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Mode of Transport
Figure 5 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Holding Temperature Range
Figure 6 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by End-user
Figure 7 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Region
Figure 8 Cell and Gene Therapy Cold Chain Logistics Market: Market Dynamics
Figure 9 Cell and Gene Therapy Cold Chain Logistics Market: Impact Analysis
Figure 10 Cell and Gene Therapy Cold Chain Logistics Market: Porter’s Five Forces Analysis
Figure 11 Cell and Gene Therapy Cold Chain Logistics Market: PEST Analysis
Figure 12 Cell and Gene Therapy Cold Chain Logistics Market by Components: Market Attractiveness Index
Figure 13 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
Figure 14 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Components, 2024, 2029, 2034 (%)
Figure 15 Cryogenic Shippers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 16 Cryogenic Shippers Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 17 Cryogenic Storage Freezers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 18 Cryogenic Storage Freezers Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Ultra-Low Freezers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 20 Ultra-Low Freezers Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Cold Chain Management Systems Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 22 Cold Chain Management Systems Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Shipment and Storage Medium Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 24 Shipment and Storage Medium Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Cryogenic Packout Kits Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 26 Cryogenic Packout Kits Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 28 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Cell and Gene Therapy Cold Chain Logistics Market by Services: Market Attractiveness Index
Figure 30 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 31 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Services, 2024, 2029, 2034 (%)
Figure 32 Transportation Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 33 Transportation Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Storage Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 35 Storage Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Packaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 37 Packaging Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Cell and Gene Therapy Cold Chain Logistics Market by Mode of Transport: Market Attractiveness Index
Figure 39 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
Figure 40 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Mode of Transport, 2024, 2029, 2034 (%)
Figure 41 Air Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 42 Air Transport Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Ground Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 44 Ground Transport Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Water Transport Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 46 Water Transport Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 47 Cell and Gene Therapy Cold Chain Logistics Market by Holding Temperature: Market Attractiveness Index
Figure 48 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
Figure 49 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Holding Temperature, 2024, 2029, 2034 (%)
Figure 50 Cryogenic Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 51 Cryogenic Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 Refrigerated Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 53 Refrigerated Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Ambient Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 55 Ambient Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 56 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 57 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 58 Cell and Gene Therapy Cold Chain Logistics Market by End-users: Market Attractiveness Index
Figure 59 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 60 Cell And Gene Therapy Cold Chain Logistics Share Forecast by End-users, 2024, 2029, 2034 (%)
Figure 61 Biopharmaceutical and Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 62 Biopharmaceutical and Biotechnology Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 63 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 64 Academic & Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 65 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 66 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 67 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
Figure 68 Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 69 Cell and Gene Therapy Cold Chain Logistics Market by Region, 2024-2034 (US$ Million, AGR %)
Figure 70 North America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
Figure 71 North America Cell and Gene Therapy Cold Chain Logistics Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 72 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 73 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2024 & 2034 (%)
Figure 74 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
Figure 75 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2024 & 2034 (%)
Figure 76 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 77 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2024 & 2034 (%)
Figure 78 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
Figure 79 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2024 & 2034 (%)
Figure 80 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
Figure 81 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2024 & 2034 (%)
Figure 82 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
Figure 83 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2024 & 2034 (%)
Figure 84 U.S. Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 85 Canada Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 86 Europe Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
Figure 87 Europe Cell and Gene Therapy Cold Chain Logistics Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 88 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 89 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2024 & 2034 (%)
Figure 90 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
Figure 91 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2024 & 2034 (%)
Figure 92 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 93 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2024 & 2034 (%)
Figure 94 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
Figure 95 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2024 & 2034 (%)
Figure 96 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
Figure 97 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2024 & 2034 (%)
Figure 98 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
Figure 99 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2024 & 2034 (%)
Figure 100 Germany Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 101 UK Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 102 France Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 103 Italy Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 104 Spain Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 105 Russia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 106 Switzerland Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 107 Belgium Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 108 Rest of Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 109 Asia Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
Figure 110 Asia Cell and Gene Therapy Cold Chain Logistics Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 111 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 112 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2024 & 2034 (%)
Figure 113 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
Figure 114 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2024 & 2034 (%)
Figure 115 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 116 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2024 & 2034 (%)
Figure 117 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
Figure 118 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2024 & 2034 (%)
Figure 119 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
Figure 120 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2024 & 2034 (%)
Figure 121 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
Figure 122 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2024 & 2034 (%)
Figure 123 Japan Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 124 China Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 125 India Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 126 Australia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 127 South Korea Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 128 Singapore Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 129 Malaysia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 130 Thailand Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 131 Rest of Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 132 Latin America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
Figure 133 Latin America Cell and Gene Therapy Cold Chain Logistics Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 134 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 135 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2024 & 2034 (%)
Figure 136 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
Figure 137 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2024 & 2034 (%)
Figure 138 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 139 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2024 & 2034 (%)
Figure 140 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
Figure 141 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2024 & 2034 (%)
Figure 142 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
Figure 143 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2024 & 2034 (%)
Figure 144 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
Figure 145 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2024 & 2034 (%)
Figure 146 Brazil Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 147 Mexico Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 148 Argentina Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 149 Rest of Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 150 MEA Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
Figure 151 MEA Cell and Gene Therapy Cold Chain Logistics Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 152 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 153 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2024 & 2034 (%)
Figure 154 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2024-2034 (US$ Million, AGR %)
Figure 155 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2024 & 2034 (%)
Figure 156 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 157 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2024 & 2034 (%)
Figure 158 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2024-2034 (US$ Million, AGR %)
Figure 159 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2024 & 2034 (%)
Figure 160 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2024-2034 (US$ Million, AGR %)
Figure 161 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2024 & 2034 (%)
Figure 162 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
Figure 163 MEA Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2024 & 2034 (%)
Figure 164 GCC Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 165 South Africa Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 166 Rest of MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 167 Cell and Gene Therapy Cold Chain Logistics Market: Company Share Analysis, 2023
Figure 168 Cencora, Inc.: Net Revenue, 2019-2023 (US$ Million, AGR%)
Figure 169 Cencora, Inc.: Regional Market Shares, 2023
Figure 170 Cencora, Inc.: SWOT Analysis
Figure 171 BioLife Solution Inc.: Net Revenue, 2019-2023 (US$ Million, AGR%)
Figure 172 BioLife Solution Inc.: R&D, 2019-2023 (US$ Million, AGR%)
Figure 173 BioLife Solution Inc: Business Segment Market Shares, 2023
Figure 174 BioLife Solution Inc.: SWOT Analysis
Figure 175 Cardinal Health: Net Revenue, 2019-2023 (US$ Million, AGR%)
Figure 176 Cardinal Health: Regional Market Shares, 2023
Figure 177 Cardinal Health: Business Segment Market Shares, 2023
Figure 178 Cardinal Health: SWOT Analysis
Figure 179 Catalent Inc.: Net Revenue, 2019-2023 (US$ Million, AGR%)
Figure 180 Catalent Inc.: Regional Market Shares, 2023
Figure 181 Catalent Inc.: Business Segment Market Shares, 2023
Figure 182 Catalent Inc.: SWOT Analysis
Figure 183 Cryoport Inc.: Net Revenue, 2019-2023 (US$ Million, AGR%)
Figure 184 Cryoport Inc.: Regional Market Shares, 2023
Figure 185 Cryoport Inc.: Business Segment Market Shares, 2023
Figure 186 DHL: SWOT Analysis
Figure 187 Marken (a UPS Company): SWOT Analysis
Figure 188 DHL: Net Revenue, 2019-2023 (US$ Million, AGR%)
Figure 189 DHL: Regional Market Shares, 2023
Figure 190 DHL: Business Segment Market Shares, 2023
Figure 191 DHL: SWOT Analysis
Figure 192 FedEx : Net Revenue, 2019-2023 (US$ Million, AGR%)
Figure 193 FedEx : Regional Market Shares, 2023
Figure 194 FedEx: SWOT Analysis
Figure 195 A.P. Moller - Maersk: Net Revenue, 2019-2023 (US$ Million, AGR%)
Figure 196 A.P. Moller - Maersk: Regional Market Shares, 2023
Figure 197 A.P. Moller - Maersk: Business Segment Market Shares, 2023
Figure 198 FedEx: SWOT Analysis

Companies Mentioned

  • A.P. Moller – Maersk
  • Arvato SE
  • Atelerix Ltd.
  • BioLife Solutions Inc.
  • BioStor Sytems Inc.
  • Cardinal Health
  • Catalent Inc.
  • Cencora, Inc.
  • CryoPort Inc.
  • DHL
  • FedEx
  • Marken (a UPS Company)
  • MasterControl Solutions, Inc.
  • Modality Solutions
  • NMDP BioTherapies
  • Nordic Cold Chain Solutions
  • Polar Express Transportation
  • sedApta s.r.l.
  • Thermo Fisher Scientific Inc.
  • TrakCel
  • Yourway
  • AbbVie
  • AbelZeta Pharma Inc.
  • Acino
  • AD Ports Logistics (ADPL)
  • Almac Clinical Services
  • AmerisourceBergen's World Courier
  • AstraZeneca
  • Autolus Therapeutics plc
  • Avery Dennison
  • Bayer AG
  • BioNTech SE
  • BioVex, Inc. (Amgen Inc.)
  • Bluebird bio
  • Bristol Myers Squibb
  • Cartherics Pty Ltd
  • Cavalier International Air Freight, Inc.
  • Cavalier Logistics Management II, Inc.
  • Celgene Corporation
  • Cell and Gene Therapy Catapult
  • Cellares
  • Cellbox Solutions GmbH
  • Cellectis
  • CellResearch Corporation
  • Central Pharma
  • Cleveland Cord Blood Center
  • CRISPR Therapeutics
  • CryoPDP
  • Csafe
  • CSL Behring LLC, UniQure
  • CSPC Pharmaceutical Group Limited (CSPC)
  • Cyto-Facto
  • DB Schenker
  • DC Dyna, Inc.
  • Decibel Therapeutics, Inc.
  • Enzyvant Therapeutics GmbH
  • Exeltainer
  • Ferring Pharmaceuticals A/S
  • Fresenius Kabi
  • Hanjin
  • Hovione
  • iBET
  • Immunoadoptive Cell Therapy Private Ltd (ImmunoACT)
  • Iovance Biotherapeutics
  • Itransition
  • Janssen Biotech, Inc.
  • Juno Therapeutics, Inc.
  • Kite Pharma, Inc.
  • Krystal Biotech
  • Kymriah
  • Laurus Labs
  • Legend Biotech
  • LifeX Ventures
  • Limula
  • Long Feng Medical Logistics
  • Lupagen Inc.
  • Miltenyi Biotec
  • Mitsubishi Logistics Corporation (Japan)
  • National Resilience Inc.
  • NIPPON EXPRESS
  • Novartis Gene Therapies, Inc.
  • Novartis Pharmaceuticals Corporation
  • Novena Global Lifecare
  • Orchard Therapeutics
  • Pelican BioThermal
  • Pfizer
  • PharmaLex Holding GmbH
  • Pharmaniaga Berhad (Pharmaniaga)
  • Porton Advanced Solutions
  • Prologis
  • ProPharma
  • Regeneron Pharmaceuticals, Inc.
  • Roche
  • Roland Berger
  • Sanofi
  • Sarepta Therapeutics, Inc.
  • Sartorius
  • Saudi Cargo, the cargo division of Saudi Arabian Airlines
  • SCG Cell Therapy
  • Scintila S.R.O
  • Sensitech
  • SkyCell
  • Spark Therapeutics, Inc.
  • Stratatech Corporation
  • Sure Chill
  • Syneos Health
  • Taikoo Motors
  • Tec4med Lifescience GmbH
  • TEIJIN CDMO
  • TICAROS
  • TiCARos Co Ltd.
  • Tower Cold Chain
  • TreeFrog Therapeutics
  • Umoja Biopharma
  • UPS Healthcare
  • va-Q-tec
  • Vertex
  • VGXI Inc.
  • ViSync Technologies
  • Vitesco Technologies
  • World Courier
  • WuXi Advanced Therapies (WuXi ATU)
  • Yinjia (Shanghai) Biosciences
  • Zuellig Pharma
  • Zühlke Ventures
  • American Cancer Society
  • American Society of Clinical Oncology
  • Argentina government
  • Argentina: National Administration on Drugs, Foods, and Medical Devices (ANMAT)
  • Argentine Network of Tissue Banks (RATI)
  • Berlin Institute of Health
  • Centers for Medicare and Medicaid Services
  • European Commission
  • Federal Government, Australia
  • Genethon, Institut Imagine, France
  • IATA Temperature Control Regulations (TCR)
  • Independent Validators (CEIV)
  • International Air Transport Association (IATA)
  • International Maritime Dangerous Goods (IMDG)
  • Korean Ministry of Food and Drug Safety (MFDS)
  • Ministry of Health, Argentina
  • National Research Council
  • National Center for Biotechnology Information (NCBI)
  • Pan American Health Organization (PAHO)
  • U.S. Food and Drug Administration (FDA)
  • World Health Organization (WHO)